|
|
Article: Research by S. Ohshimo and colleagues in cystic fibrosis provides new insights.
- Article from:
- Biotech Week
- Article date:
- November 11, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
"Cystic fibrosis (CF) is a chronic progressive disease leading to obstructive pulmonary impairment, fibrosis and shortened life expectancy. Serum levels of KL-6, high molecular weight human MUC1 mucin, are increased in the majority of patients with various interstitial lung disorders," scientists in Essen, Germany report (see also Cystic Fibrosis).
"Whether they are also elevated in CF has not been investigated before. To evaluate whether serum KL-6 levels are elevated and correlate With pulmonary function variables in CF Design: Serum KL-6, lactate dehydrogenase (LDH) and C-reactive protein (CRP) levels were measured in 72 consecutive CF and 80 age- and ...